Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman is battling rumors surrounding superintelligence and AGI (artificial general intelligence). Is ChatGPT ...
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...